Lundbeck Q3 2019 Financial Results

Northera shows solid growth in sales and demand Grew 25% (18% in L.C.) to DKK 1,606 million in 9M 2019 I Northera sales (Quarterly - DKKm) +38% 1.750 Volume is up 18% 1) compared to Q3 2018 600 1.500 Northera impacted by normal quarterly fluctuations driven by e.g. seasonality and pharmacies' buying pattern Lundbeck only promotes Northera in the U.S. 1) Symphony Health (cf. Bloomberg) 9 450 300 150 0 Q3.17 Q3.18 Q3.19 1.250 1.000 750 500 250 Northera sales (9M - DKKm) +25% 9M.17 9M.18 9M.19 Lundbeck

View entire presentation